OPTIMUM RX

Serial Number 75560217
Registration 2627068
710

Registration Progress

Application Filed
Sep 28, 1998
Under Examination
Approved for Publication
Jun 19, 2002
Published for Opposition
Jul 9, 2002
Registered
Oct 1, 2002

Trademark Image

OPTIMUM RX

Basic Information

Serial Number
75560217
Registration Number
2627068
Filing Date
September 28, 1998
Registration Date
October 1, 2002
Published for Opposition
July 9, 2002
Cancellation Date
May 16, 2009
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
May 16, 2009

Rights Holder

L'Oreal USA, Inc.

03
Address
575 Fifth Avenue
New York, NY 10017

Ownership History

Amethyst Investment Group, Inc.

Original Applicant
03
Chicago, IL

L'Oreal USA, Inc.

New Owner Before Publication #1
03
New York, NY

L'Oreal USA, Inc.

Owner at Publication
03
New York, NY

L'Oreal USA, Inc.

Original Registrant
03
New York, NY

Legal Representation

Attorney
LISA M GIGLIOTTI

USPTO Deadlines

Next Deadline
2527 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2002-10-01)
Due Date
October 01, 2032
Grace Period Ends
April 01, 2033

Application History

13 events
Date Code Type Description Documents
May 16, 2009 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Jan 28, 2008 CFIT O CASE FILE IN TICRS Loading...
Oct 1, 2002 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 9, 2002 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2002 NPUB O NOTICE OF PUBLICATION Loading...
Apr 18, 2002 MAIL I PAPER RECEIVED Loading...
Mar 26, 2002 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 16, 2000 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 28, 1999 CNSL F LETTER OF SUSPENSION MAILED Loading...
Aug 20, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 23, 1999 CNRT F NON-FINAL ACTION MAILED Loading...
Feb 12, 1999 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 5, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"RX"